Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.23.3
Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Common Shares Issuable
Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Total
Balance at Dec. 31, 2021 $ 3 $ 7   $ 656,127 $ (547,463) $ 117,203 $ 225,877
Balance (in shares) at Dec. 31, 2021 3,427,138 6,762,367          
Stock-based compensation expense       17,481     17,481
Issuance of common stock related to equity plans (in shares)   196,913          
Issuance of common stock under ESPP       99     99
Issuance of common stock under ESPP (in shares)   9,030          
Issuance of common stock for at-the-market offering, net       5,750     5,750
Issuance of common stock for at-the-market offering, net (in shares)   248,978          
Preferred A dividends declared and paid       (6,024)     (6,024)
Adjustments To Additional Paid In Capital Subsidiary At Market Offering       16,193     16,193
Partner company's at-the-market offering, net       16,193     16,193
Partner company's exercise of options for cash       142     142
Issuance of common stock under partner company's ESPP       206     206
Partner company's dividends declared and paid       (563)     (563)
Partner company's net settlement of shares withheld for taxes       (1,698)     (1,698)
Reversal of partner company's common shares for research and development expenses       (27)     (27)
Warrants       384     384
Non-controlling interest in partner companies       (19,319)   19,319  
Net loss attributable to non-controlling interest           (96,841) (96,841)
Net loss attributable to common stockholders         (59,627)   (59,627)
Balance at Sep. 30, 2022 $ 3 $ 7   $ 668,751 (607,090) 39,681 101,352
Balance (in shares) at Sep. 30, 2022 3,427,138 7,217,288   668,751,000      
Balance at Jun. 30, 2022 $ 3 $ 7   $ 661,792 (584,579) 70,479 147,702
Balance (in shares) at Jun. 30, 2022 3,427,138 7,181,175          
Stock-based compensation expense       $ 6,837     6,837
Issuance of common stock related to equity plans (in shares)   20,488          
Issuance of common stock for at-the-market offering, net             223
Issuance of common stock for at-the-market offering, net (in shares)   15,625   223,000      
Preferred A dividends declared and paid       $ (2,008)     (2,008)
Adjustments To Additional Paid In Capital Subsidiary At Market Offering       (1,717)     (1,717)
Partner company's at-the-market offering, net       (1,717)     (1,717)
Partner company's exercise of options for cash       31     31
Issuance of common stock under partner company's ESPP       90     90
Partner company's dividends declared and paid       (188)     (188)
Issuance (Reversal) of partner company's common shares for research and development expenses       8     8
Non-controlling interest in partner companies       249   (249)  
Net loss attributable to non-controlling interest           (30,549) (30,549)
Net loss attributable to common stockholders         (22,511)   (22,511)
Balance at Sep. 30, 2022 $ 3 $ 7   $ 668,751 (607,090) 39,681 101,352
Balance (in shares) at Sep. 30, 2022 3,427,138 7,217,288   668,751,000      
Balance at Dec. 31, 2022 $ 3 $ 7   $ 675,944 (634,233) 8,304 50,025
Balance (in shares) at Dec. 31, 2022 3,427,138 7,366,283          
Stock-based compensation expense       13,325     13,325
Issuance of common stock related to equity plans (in shares)   211,969          
Issuance of common stock for public offering, net   $ 1   13,154     13,155
Issuance of common stock for public offering, net (in shares)   1,109,525          
Issuance of common stock for at-the-market offering, net   $ 1   2,004     2,005
Issuance of common stock for at-the-market offering, net (in shares)   224,003          
Common shares issued for dividend on partner company's convertible preferred shares       199     199
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   25,807          
Preferred A dividends declared and paid       (6,024)     (6,024)
Partner company's offering, net       31,238     31,238
Adjustments To Additional Paid In Capital Subsidiary At Market Offering       160     160
Partner company's at-the-market offering, net       160     160
Partner company's exercise of options for cash       24     24
Issuance of common stock under partner company's ESPP       178     178
Partner company's dividends declared and paid       (556)     (556)
Issuance (Reversal) of partner company's common shares for research and development expenses       1,233     1,233
Warrants       272     272
Deconsolidation/dissolution of subsidiary non-controlling interests           6,693 6,693
Non-controlling interest in partner companies       (28,898)   28,898  
Net loss attributable to non-controlling interest           (73,812) (73,812)
Net loss attributable to common stockholders         (51,358)   (51,358)
Balance at Sep. 30, 2023 $ 3 $ 9   702,253 (685,591) (29,917) (13,243)
Balance (in shares) at Sep. 30, 2023 3,427,138 8,937,587          
Balance at Jun. 30, 2023 $ 3 $ 9 $ 23 699,020 (680,546) (34,452) (15,943)
Balance (in shares) at Jun. 30, 2023 3,427,138 8,777,157          
Stock-based compensation expense       4,377     4,377
Issuance of common stock related to equity plans (in shares)   28,112          
Issuance of common stock for at-the-market offering, net       837     837
Issuance of common stock for at-the-market offering, net (in shares)   117,578          
Common shares issued for dividend on partner company's convertible preferred shares     $ (23) 91     68
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   14,740          
Preferred A dividends declared and paid       (2,008)     (2,008)
Partner company's offering, net       9,261     9,261
Adjustments To Additional Paid In Capital Subsidiary At Market Offering       160     160
Partner company's at-the-market offering, net       160     160
Partner company's exercise of options for cash       21     21
Issuance of common stock under partner company's ESPP       90     90
Partner company's dividends declared and paid       (185)     (185)
Deconsolidation/dissolution of subsidiary non-controlling interests           802 802
Non-controlling interest in partner companies       (9,412)   9,412  
Net loss attributable to non-controlling interest           (5,679) (5,679)
Net loss attributable to common stockholders         (5,045)   (5,045)
Balance at Sep. 30, 2023 $ 3 $ 9   $ 702,253 $ (685,591) $ (29,917) $ (13,243)
Balance (in shares) at Sep. 30, 2023 3,427,138 8,937,587